share_log

Innoviva Analyst Ratings

Benzinga Analyst Ratings ·  Jan 24, 2023 08:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/24/2023 0.46% Morgan Stanley $14 → $13 Maintains Underweight
10/13/2022 8.19% Morgan Stanley $13 → $14 Maintains Underweight
08/08/2022 0.46% Morgan Stanley $12 → $13 Maintains Underweight
07/20/2022 23.65% Goldman Sachs → $16 Initiates Coverage On → Neutral
07/15/2022 -7.26% Morgan Stanley $13 → $12 Maintains Underweight
04/12/2022 0.46% Morgan Stanley $12 → $13 Maintains Underweight
02/23/2022 -7.26% Morgan Stanley $10 → $12 Maintains Underweight
02/11/2022 116.38% EF Hutton → $28 Initiates Coverage On → Buy
11/11/2020 -22.72% Morgan Stanley $8 → $10 Maintains Underweight
06/25/2018 — Stifel Terminates Coverage On Hold → Hold
04/27/2018 23.65% Stifel $17 → $16 Maintains Hold

What is the target price for Innoviva (INVA)?

There is no price target for Innoviva

What is the most recent analyst rating for Innoviva (INVA)?

There is no analyst for Innoviva

When is the next analyst rating going to be posted or updated for Innoviva (INVA)?

There is no next analyst rating for Innoviva

Is the Analyst Rating Innoviva (INVA) correct?

There is no next analyst rating for Innoviva

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment